Identifying and addressing gaps in Australia’s adolescent HPV vaccination program

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Australia was the first country to implement a national vaccination program for human papillomavirus (HPV) which is the primary cause of cervical cancer. However national vaccination coverage remains suboptimal at 77% in girls. Through a partnership between researchers and health departments (Tasmania, Western Australia and New South Wales) we will conduct research to determine barriers to vaccination and evaluate the cost and impact of innovative strategies to increase vaccination coverage.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2022

Funding Scheme: Partnerships

Funding Amount: $689,723.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adolescent health | evaluation | human papillomavirus (HPV) | implementation | vaccine strategy